Blue Citrus
Joint Pain
Legacy Health SystemN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Joint Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Naltrexone Mundipharma Pte Ltd. | Phase 4 | BB |
Buprenorphine Mundipharma Pte Ltd. | Phase 4 | BB |
Maltodextrin RDC Clinical Pty Ltd | Phase 3 | BB |
Maolactin RDC Clinical Pty Ltd | Phase 3 | BB |
Chondroitin Baylor Breast Care Center | Phase 2 | B |
View all 15 →
Same molecule, other indications
Blue Citrus is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →